5 regulatory mistakes companies make when entering the Portuguese market

PhaRegistrum · Originally published on 30/10/2026

Entering Portugal may look straightforward when your product is already compliant with EU legislation. But EU compliance does not always mean that a product is immediately ready for the Portuguese market.

National requirements, notifications and local procedures still need to be considered.

1. Assuming EU compliance is enough

Depending on the product category, additional national procedures may apply before placing the product on the Portuguese market.

2. Leaving Portuguese labelling requirements until the end

Translations should not be treated as a final administrative step. Mandatory information and claims should be assessed from a regulatory perspective. Some claims may be accepted in other EU countries but viewed as non-compliant by the national authorities.

3. Missing national fees’ payment

Depending on the product, interactions with authorities such as INFARMED, DGS or DGAV may be required and, in some cases, a fee payment is necessary to commercialise products in Portugal.

4. Underestimating the role of the local supply chain

Importer, distributor, manufacturer and responsible person obligations are not interchangeable and have some particularities in Portugal.

5. Thinking about regulatory compliance only at launch

Regulatory obligations continue long after market entry. Appropriate communication of product changes, safety information and vigilance monitoring, revision of advertising materials and notifications to health authorities are national obligations to consider.

At PhaRegistrum, we support companies entering the Portuguese market with regulatory strategy, product assessment, registrations and notifications, labelling review and ongoing regulatory support.

View the carousel in the original LinkedIn post to discover the five mistakes covered.

View original post on LinkedIn

Back to the publication archive